Cello Health plc Stock price

Equities

CLL

GB00B0310763

Delayed London S.E. 5-day change 1st Jan Change
- GBX -.--% Intraday chart for Cello Health plc -0.31% +19.70%
Sales 2018 166M 209M Sales 2019 167M 211M Capitalization 143M 180M
Net income 2018 6M 7.57M Net income 2019 - 0 EV / Sales 2018 0.66 x
Net cash position 2018 6.34M 8M Net Debt 2019 3.58M 4.52M EV / Sales 2019 0.88 x
P/E ratio 2018
18.1 x
P/E ratio 2019
-155 x
Employees -
Yield 2018
3.47%
Yield 2019
1.6%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Value Demonstration UK Holdings Limited completed the acquisition of Cello Health plc. CI
Value Demonstration UK Holdings Limited reached an agreement to acquire Cello Health plc for approximately £170 million. CI
Access Intelligence Plc commences an Equity Buyback Plan for 4,076,238 shares, for £0.000001 million, under the authorization approved on May 20, 2020. CI
Tranche Update on Access Intelligence Plc's Equity Buyback Plan announced on June 4, 2020. CI
Access Intelligence Plc's Equity Buyback announced on February 6, 2020, has closed with 4,076,238 shares, for £1 million. CI
Cello Health plc Withdraws Recommendation to Pay Final Dividend CI
Cello Health plc Withdraws Final Dividend; Declares Interim Dividend, Payable on May 22, 2020 CI
Cello Health plc Proposes Final Dividend, Payable on May 22, 2020 CI
Cello Health plc Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Access Intelligence Plc acquired Fenix Media Limited and Face US Inc. from Cello Health plc and Cello Health Inc. for £4.7 million. CI
Cello Health plc Announces Interim Dividend, Payable on November 1, 2019 CI
Cello Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 CI
Cello Health plc acquired trade and assets of Innovative Science Solutions, LLP for $10.5 million. CI
Cello Health plc Provides Earnings Guidance for the Full Year 2019 CI
Cello Health Intends To Seek Acquisitions CI
More news
Managers TitleAgeSince
Chief Operating Officer - -
Director/Board Member 54 -
Corporate Secretary - -
Members of the board TitleAgeSince
Director/Board Member 47 -
Director/Board Member 54 -
Director/Board Member 64 -
More insiders
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock Cello Health plc - London S.E.